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In randomised trials, internal validity is
defined as ‘‘the extent to which the design
and conduct of a study are likely to have
prevented bias’’ [1,2]. In conducting such
trials, trialists try to prevent selection bias
through randomisation and allocation
concealment (defined as ‘‘the process used
to ensure that the person deciding to enter
a participant into a randomised controlled
trial does not know the comparison group
into which that individual will be allocat-
ed’’ [2]) and attrition bias through an
intention-to-treat (ITT) analysis. ITT
analysis has indeed been defined as one
of the cornerstones of the analysis strategy
of randomised trials because it allows for
preserving the benefits of randomisation
[3]. With an ITT analysis, data for all
randomised participants are analysed in
the groups to which they were originally
randomly allocated ‘‘regardless of their
adherence with the entry criteria, regard-
less of the treatment they actually received,
and regardless of subsequent withdrawal
from treatment or deviation from the
protocol’’ [4]. ITT analysis entails the
use of ad hoc statistical methods to handle
missing outcome data when participants
withdraw from the trial or are lost to
follow-up [4,5]. The ITT principle is
widely used in analysing data from indi-
vidually randomised trials but is much
more difficult in cluster randomised trials
(CRTs), and this issue is not clearly
covered in the main methodological text-
books on the topic [6,7].
Here, we describe the difficulties in
preventing selection bias and applying
ITT analysis in CRTs (other biases are
discussed in Puffer et al. [8]) and propose
some solutions to deal with these issues in
this trial design.
CRTs: Randomising Clusters
Rather Than Individuals
In CRTs, ‘‘intact social units, or clusters
of individuals, rather than individuals
themselves, are randomised’’ [6]. For
example, hospitals, wards, or physicians
can be randomised, as well as schools or
geographical areas. Such a design is well
adapted to assess organisational and be-
havioural interventions and health promo-
tion programmes—interventions that are
usually implemented at the level of health
organisational units or geographical areas
[9]. As well, randomisation of clusters
rather than individuals could prevent
contamination. As an example, to assess
the impact of a screening programme,
widespread publicity is needed to encour-
age participants to undergo screening.
With individual randomisation, communi-
cation among participants would induce
contamination, but with cluster randomi-
sation, it may strengthen participant
compliance.
Use of the CRT has greatly increased
over the past 15 years [10] and has
motivated the publication of an extension
of the CONSORT Statement for this
design [11] because of its particular
methodological issues. The main issue is
that observations from the same cluster are
more similar than observations from two
different clusters. This situation requires
the use of both an inflated sample size and
adapted statistical analysis to take into
account this concern [6,7]. Otherwise, for
the recruitment process, we can distin-
guish two different designs: a whole CRT
or a CRT with active recruitment. In the
first design, once the person in charge of
the cluster (the cluster guardian [12]) has
agreed to participate, every individual
belonging to the cluster is automatically
recruited for the trial; in the second design,
the guardian (or someone other than the
guardian but depending on the guardian)
must select and include participants for the
trial. Also, Murray distinguishes between
cohort designs, whereby a sample of
participants is included, followed up, and
assessed repeatedly (as is usually done in
individually randomised trials), and re-
peated cross-sectional designs, whereby a
distinct sample of participants is assessed
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Summary Points
N In CRTs, the comparability of
groups is challenged because
groups of trial participants rather
than the participants themselves
are randomised.
N The specific chronology of such
trials compromises allocation con-
cealment (i.e., clusters are recruit-
ed and randomised and then
participants are recruited), which
can induce differential recruit-
ment and thus quantitative and
qualitative imbalance between
groups.
N The principle of intention to treat
is challenged in CRTs because of
the lack of any statistical method
to handle non-recruited partici-
pants.
N Empty clusters (i.e., clusters with
no data for participants), which
are randomised units, are discard-
ed from the analysis—a violation
of the very principle of intention
to treat.
N Some CRTs may be better ana-
lysed as observational studies,
with some form of adjustment
used such as propensity-score
methods.
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Figure 1. Recruitment issues in cluster randomised trials.
doi:10.1371/journal.pmed.1000065.g001
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at each assessment time [7]. Such a
distinction makes sense only in whole
CRTs. The design is always a cohort one
when it involves active recruitment.
The Challenge of Comparability
of Groups in CRTs
In individually randomised trials, ran-
domisation and allocation concealment
aim to prevent selection bias and allow
for the comparability of groups at the
beginning of the study. The aim of ITT
analysis is to maintain this comparability
during analysis. In CRTs, the situation is
more complex because (i) the design
entails a hierarchical structure (cluster
and individual levels) and (ii) recruitment
and follow-up processes differ from those
in individually randomised trials.
First, the hierarchical structure of CRTs
requires the consideration of both the
cluster and individual levels. When El-
bourne et al. [13] appealed for an extension
of the CONSORT Statement to CRTs,
they explicitly stated that authors must
report whether ‘‘[the ITT] principle applies
to clusters, individuals or both’’. Campbell
defined ITT analysis in CRTs as taking into
account all participants, regardless of
whether non-adherence to the protocol
occurred at the individual or cluster level
[14]. Indeed, in CRTs, participants lost to
follow-up and protocol deviation can occur
at the level of the cluster (cluster withdrawal
or lost to follow-up, inactive cluster, merg-
ing of clusters) or the individual (participant
withdrawal or lost to follow-up, or transfer
from one cluster to another). Moreover,
results of a CRT can be analysed by
considering the individual or cluster as the
statistical unit. Even in the latter case, a
summary statistic is estimated from individ-
ual responses within each cluster. There-
fore, the comparability of groups must be
achieved at both the cluster (i.e., for
randomised units) and individual levels.
Second, in a CRT, both recruitment and
follow-up raise specific issues that may
compromise the comparability of groups
(Figures 1 and 2). The usual definition of an
ITT analysis in CRTs is restrictive because it
focuses only on follow-up issues. However,
during the recruitment process, clusters may
withdraw, or cluster guardians may not
actively recruit participants; these situations
lead to empty clusters, which should be taken
into account to apply the ITT principle.
Another important issue is differential re-
cruitment between active clusters, which
could be both quantitative (i.e., different
number of participants recruited) and qual-
itative (i.e., participants with different char-
acteristics recruited in both groups). As an
example, in the UK BEAM trial, 71.4% of
recruited participants were in the interven-
tion group, even though the randomisation
was 1:1, and groups were not comparable on
several clinically important criteria [15].
Eldridge et al. concluded that ‘‘about a
quarter [of CRTs] were potentially biased
because of procedures surrounding recruit-
ment and identification of patients’’ [16], as
previously acknowledged by Puffer et al. [8].
The Challenge of Applying ITT
Analysis in CRTs
In CRTs, cluster withdrawal or loss to
follow-up and participant withdrawal or
loss to follow-up must be handled as is
usually done in individually randomised
trials, by use of ad hoc missing data
methods [17,18]. More specific to CRTs
Figure 2. Follow-up issues in cluster randomised trials.
doi:10.1371/journal.pmed.1000065.g002
Essay
PLoS Medicine | www.plosmedicine.org 3 May 2009 | Volume 6 | Issue 5 | e1000065
are participant switches from one cluster
to another (e.g., patients who change
physicians) and cluster merging (e.g., two
medical practices that merge). These
follow-up issues are not problematic per
se and can be easily handled by keeping
clusters as they were randomised. Thus,
participants who switch from one cluster
to another must be kept in their original
cluster, and merged clusters must be split.
The major difference between individu-
ally randomised trials and CRTs in apply-
ing the ITT principle is that in the former,
we know which participants were rando-
mised and must be taken into account in the
ITT analysis, whereas in CRTs, we know
which clusters have been randomised but
we frequently do not know exactly which
participants within clusters should have
been included in the trial. Whole CRTs
and CRTs with active recruitment raise
distinct issues, but for both, this dilemma is
the real challenge of applying ITT analysis
and preserving the comparability of groups.
Whole CRTs
In whole CRTs, empty clusters occur
when cluster guardians withdraw just after
the randomisation and before any data on
participants are collected. The guardians
make these decisions once they know the
allocation result, which could influence the
likelihood of withdrawal. So excluding such
empty clusters from analysis (as is always
done) is in essence post-randomisation
exclusion. Furthermore, in CRTs, the
number of randomised units is much lower
than that in individually randomised trials,
so any randomised unit has greater influ-
ence in a CRT than in an individually
randomised trial. Also, in CRTs with empty
clusters, although we know some cluster
characteristics, often we do not know the
number or characteristics of participants
who should have been included in those
clusters if they had been active. This
scenario prevents the use of any statistical
solution: knowing cluster characteristics
does not allow in any way the derivation
of participant characteristics. Such rando-
mised clusters that lack any data on
participants are then removed before anal-
ysis, which violates the very definition of the
ITT (i.e., exclusion of randomised units). In
CRTs, therefore, extreme vigilance is
needed to ensure cluster guardians’ adher-
ence to the trial protocol, before the
randomisation of the clusters they are in
charge of, because currently, we lack
statistical methods to limit the induced bias.
CRTs with Active Recruitment
As emphasised, CRTs with active re-
cruitment ‘‘first recruit the clusters, then
Box 1: Recommendations for the Planning of and Analysis of
Data in CRTs To Improve the Comparability of Groups
Handling Recruitment Issues
Cluster level:
N Monitor cluster guardians’ adherence to the protocol before the randomisation
of the cluster they are in charge of.
N For whole CRTs, this monitoring will help prevent clusters withdrawing after
randomisation and before the collection of data for participants.
N For CRTs with active recruitment, this monitoring will help prevent empty
clusters due to inactivity of guardians.
Individual level:
Whole CRTs
N Ensure the inclusion of all participants belonging to the randomised clusters.
N For a cohort design (i.e., participants are included, followed up, and assessed):
N Consider participants who migrate out of clusters (out-migrants) as being
withdrawn or lost to follow-up.
N Discard data for participants who migrate into a cluster (in-migrants).
CRTs with active recruitment
N Whenever possible, identify and completely include participants before
randomising a cluster, to maintain the usual chronology of a randomised trial
(recruitment followed by randomisation) and help prevent selection bias.
If complete inclusion of participants is not possible, the following two solutions
can be used in combination:
N If possible, randomise clusters only when the first participant is included (index
case concept) to prevent empty clusters.
N If possible, have blinded independent recruiters include participants, so that the
inclusion process can be independent from the allocation process.
Analysis: Handling Follow-Up Issues
Cluster level:
N Take into account any cluster that withdrew or was lost to follow-up by using
ad hoc missing data methods for participants included in these clusters.
N If two or more clusters merge during the trial, split the merged clusters so that
the clusters analysed are those that were initially recruited.
Individual level:
N Take into account any participant who withdrew or was lost to follow-up by
using ad hoc missing data methods.
N Keep any participant who transferred from one cluster to another in the original
cluster.
Analysis: Handling Quantitative and Qualitative Imbalance between
Intervention Groups
Whole CRTs:
N Use adjustment methods to cope with potential imbalances in both cluster and
individual characteristics, which are frequent when the number of randomised
clusters is small.
CRTs with active recruitment:
N Calibrateestimationbyusingweightingadjustments(e.g.,propensity-scoremethods)
to deal with quantitative and qualitative imbalance due to potential differential
recruitment induced by lack of allocation concealment when including participants.
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randomise and finally recruit the partici-
pants: such an approach invites bias’’ [19].
In the extreme, some cluster guardians may
be inactive (i.e., they do not recruit any
participants), and these inactive guardians
may moreover be more numerous in one
group than in another. This situation is
similar to ‘‘passive withdrawal’’: guardians
are inactive recruiters because they do not
adhere to the allocation result (i.e., the
cluster they are in charge of has not been
randomised to the group they expected to
be in). Actually, any time recruitment of
participants occurs after randomisation, (i)
participants are selected by someone who
could be aware of the group to which the
participants will be allocated, and (ii)
participants consent not to random alloca-
tion but rather to participation in and
allocation to a pre-determined group, which
could induce differential recruitment or
consent and selection bias [8,20,21]. The
only way to prevent differential recruitment
is to ensure some form of allocation
concealment during recruitment. Puffer et
al. [8] proposed the identification and
complete inclusion of participants before
the randomisation of a cluster, which allows
for maintenance of the usual chronology of
a randomised trial. Such a strategy thus
prevents both empty randomised clusters
and selection bias but cannot be systemat-
ically implemented for logistical reasons
(e.g., in a trial including incident patients
rather than prevalent cases). Two comple-
mentary solutions are (i) changing the time
of randomisation by randomising clusters
only when the first participant is identified
(the index case concept) and (ii) blinding
independent recruiters to the allocation
group. The index case concept could
prevent empty clusters but does not prevent
differential recruitment.
Actually, some similarity exists be-
tween this potential differential recruit-
ment in CRTs and survey non-response.
Non-response is a source of bias because
non-responders are not a random sample
of surveyed people. In CRTs, partici-
pants included without allocation con-
cealment are not a random sample of
eligible participants. In the context of
survey non-response, much work has
been done to calibrate estimation, and
methods such as weighting adjustments
or imputations are classically used
[22,23]. In CRTs, the situation is more
complex because contrary to surveys, the
number of eligible participants is not
known. However, the question remains as
to whether all CRTs really benefit from
randomisation and whether some trial
results would be better analysed as
observational studies with some form of
adjustment used, such as propensity
scores [24,25]. Some methodologists
have resorted to such a solution [26,27],
which raises another issue: ‘‘how the
levels of the individual subject and the
cluster should be considered in the
estimation and application of propensity
scores’’ [28]. Further statistical research
to transpose such methods specifically to
CRTs is therefore warranted.
We provide some recommendations for
the planning and analysis of data in CRTs
to improve the comparability of groups in
such trials in light of the issues of
recruitment and ITT analysis (Box 1):
some issues may be easily handled,
whereas others remain without a solution.
Conclusion
The application of the ITT principle in
analysis of data is much more complex in
CRTs than in individually randomised trials
because the principle must be applied at the
level of both the cluster and the individual,
and because of challenging issues surround-
ing the recruitment process in CRTs. These
issues raise concerns regarding the internal
validity of such trials.
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